Immune mechanisms in fibrotic pulmonary sarcoidosis.


Journal

European respiratory review : an official journal of the European Respiratory Society
ISSN: 1600-0617
Titre abrégé: Eur Respir Rev
Pays: England
ID NLM: 9111391

Informations de publication

Date de publication:
31 Dec 2022
Historique:
received: 04 09 2022
accepted: 21 10 2022
entrez: 21 12 2022
pubmed: 22 12 2022
medline: 24 12 2022
Statut: epublish

Résumé

Sarcoidosis is an immune-mediated disorder. Its immunopathology has been steadily mapped out over the past few decades. Despite this, the underpinning mechanisms for progressive fibrotic sarcoidosis is an almost uncharted area. Consequently, there has been little change in the clinical management of fibrotic sarcoidosis over the decades and an unfocused search for new therapeutics. In this review, we provide a comprehensive examination of the relevant immune findings in fibrotic and/or progressive pulmonary sarcoidosis and propose a unifying mechanism for the pathobiology of fibrosis in sarcoidosis.

Identifiants

pubmed: 36543347
pii: 31/166/220178
doi: 10.1183/16000617.0178-2022
pmc: PMC9879330
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NHLBI NIH HHS
ID : R41 HL129728
Pays : United States

Commentaires et corrections

Type : ErratumIn

Informations de copyright

Copyright ©The authors 2022.

Déclaration de conflit d'intérêts

Conflict of interest: P. Weeratunga has received support for the present manuscript from the University of Oxford Nuffield Department of Medicine Studentship. Conflict of interest: D.R. Moller has received support for the present manuscript from the National Heart, Lung and Blood Institute, payments made to Johns Hopkins. Royalties or licenses outside the submitted work: Hodder Education for editing a book on sarcoidosis, Taylor and Francis Group for editing a book on ILD. Consulting fees received outside the submitted work from: Roivant and SarcoMed. Speaker fees received from the Trinity Postgraduate Respiratory Conference, outside the submitted work. Patents planned, issued or pending: Patent No. 9,683,999 B2 (issued, not licensed or royalties), Patent No. 9,977,029 B2 (issued, not licensed or royalties), Patent No. 11,041,862 B2 (issued, not licensed or royalties), Patent Application No. 17/319,211 (pending, not licensed or royalties). Leadership or fiduciary role in other board, society, committee or advocacy group, paid or unpaid: Foundation for Sarcoidosis Research (former member of Scientific Advisory Board, unpaid). Other financial or non-financial interests: Chairman and Chief Technical Officer for Sarcoidosis Diagnostic Testing, LLC, the company goal is to develop a diagnostic blood test for sarcoidosis and the company has received funding including past salary support under the NHLBI STTR program, grant R41 HL129728 over 3 years ago. Conflict of interest: L-P. Ho has received support for the present manuscript from Medical Research Council core funding.

Références

Science. 2022 Feb 11;375(6581):671-677
pubmed: 35143297
Am J Respir Crit Care Med. 2015 Sep 15;192(6):727-36
pubmed: 26051272
Lancet. 2005 Mar 19-25;365(9464):1062-72
pubmed: 15781102
Immunity. 2016 Mar 15;44(3):439-449
pubmed: 26982352
Trends Immunol. 2020 Apr;41(4):286-299
pubmed: 32122794
Eur Respir J. 2011 Jul;38(1):169-75
pubmed: 21148227
Cells. 2022 Feb 14;11(4):
pubmed: 35203313
Am J Respir Crit Care Med. 2013 Dec 15;188(12):1442-50
pubmed: 24070541
J Immunol. 2009 Dec 1;183(11):7297-306
pubmed: 19917689
Genes Immun. 2011 Sep;12(6):490-4
pubmed: 21562576
Am J Respir Cell Mol Biol. 2003 Dec;29(6):743-9
pubmed: 12805086
Annu Rev Immunol. 2012;30:531-64
pubmed: 22224781
J Clin Immunol. 2009 Jan;29(1):78-89
pubmed: 18773284
Sarcoidosis Vasc Diffuse Lung Dis. 2002 Jun;19(2):83-95
pubmed: 12102613
J Clin Invest. 2009 Jun;119(6):1583-94
pubmed: 19451692
Clin Exp Immunol. 2007 Sep;149(3):453-62
pubmed: 17565608
Nat Immunol. 2017 Mar;18(3):293-302
pubmed: 28092373
Am J Respir Cell Mol Biol. 2011 Jun;44(6):870-8
pubmed: 20705941
Respir Investig. 2012 Sep;50(3):104-9
pubmed: 23021769
Clin Immunol. 2010 Oct;137(1):89-101
pubmed: 20674506
Am J Respir Crit Care Med. 2009 Jun 15;179(12):1121-30
pubmed: 19342412
J Allergy Clin Immunol. 2002 May;109(5):758-70
pubmed: 11994696
Arthritis Rheum. 2006 Aug;54(8):2643-55
pubmed: 16868995
Lancet Respir Med. 2014 Feb;2(2):123-30
pubmed: 24503267
Thorax. 2010 Oct;65(10):939-40
pubmed: 20805159
J Hepatol. 2010 Mar;52(3):315-21
pubmed: 20129690
Am J Respir Cell Mol Biol. 2019 Jan;60(1):96-105
pubmed: 30141971
Am J Respir Crit Care Med. 2008 Feb 1;177(3):321-9
pubmed: 17975199
Eur Respir J. 2011 Dec;38(6):1368-73
pubmed: 22075486
Tissue Antigens. 2011 Feb;77(2):112-7
pubmed: 21214523
Front Immunol. 2020 Dec 08;11:567342
pubmed: 33363531
Am J Respir Crit Care Med. 2010 Feb 15;181(4):360-73
pubmed: 19910611
Nat Rev Rheumatol. 2014 Dec;10(12):706-19
pubmed: 25136781
Immunity. 2019 Sep 17;51(3):451-464.e6
pubmed: 31471108
Transpl Immunol. 2010 Oct;24(1):17-25
pubmed: 20850528
J Exp Med. 2003 Oct 20;198(8):1179-88
pubmed: 14557415
Am J Physiol Lung Cell Mol Physiol. 2003 Dec;285(6):L1255-62
pubmed: 12857673
Eur J Immunol. 1998 Sep;28(9):2619-29
pubmed: 9754550
Cell Tissue Res. 2017 Mar;367(3):651-661
pubmed: 27807704
Chest. 2002 Jul;122(1):233-8
pubmed: 12114364
Eur Respir J. 2021 Jun 17;57(6):
pubmed: 33602861
Rheumatology (Oxford). 2012 Jan;51(1):37-46
pubmed: 22075064
Respir Investig. 2019 Sep;57(5):430-434
pubmed: 31031123
Nat Genet. 2008 Sep;40(9):1103-6
pubmed: 19165924
Curr Opin Rheumatol. 2004 Nov;16(6):739-45
pubmed: 15577613
Elife. 2019 May 01;8:
pubmed: 30946009
Nat Commun. 2016 Oct 11;7:13048
pubmed: 27725632
Cell. 2020 Mar 19;180(6):1044-1066
pubmed: 32164908
Cytokine. 2013 Mar;61(3):906-11
pubmed: 23384655
Am J Respir Crit Care Med. 1999 Aug;160(2):736-55
pubmed: 10430755
Infect Immun. 2006 Mar;74(3):1471-9
pubmed: 16495517
Eur Respir J. 2016 Aug;48(2):484-94
pubmed: 27230441
J Clin Invest. 1999 Sep;104(6):777-85
pubmed: 10491413
Genes Immun. 2013 Jan;14(1):13-8
pubmed: 23151485
Clin Exp Immunol. 2014 Nov;178(2):342-52
pubmed: 24962673
Lung. 1998;176(2):75-87
pubmed: 9500293
Cytokine. 2014 Apr;66(2):119-26
pubmed: 24418172
Oncotarget. 2017 Nov 23;8(65):109238-109246
pubmed: 29312604
Am J Respir Crit Care Med. 2016 Jun 1;193(11):1281-91
pubmed: 26649486
Am J Respir Crit Care Med. 2010 Jun 15;181(12):1367-75
pubmed: 20194811
Eur Respir J. 2021 Jul 22;58(1):
pubmed: 33446605
Am J Respir Crit Care Med. 2009 Apr 15;179(8):717-23
pubmed: 19179488
Annu Rev Physiol. 2017 Feb 10;79:541-566
pubmed: 27813830
Nat Immunol. 2020 Sep;21(9):974-982
pubmed: 32747813
Front Immunol. 2021 Mar 05;12:623430
pubmed: 33746960
J Intern Med. 2012 Jan;271(1):90-103
pubmed: 21682779
Thorax. 2021 Jan;76(1):4-20
pubmed: 33268456
Immunity. 2019 Mar 19;50(3):692-706.e7
pubmed: 30824326
PLoS Pathog. 2009 Jun;5(6):e1000474
pubmed: 19521507
Eur Respir J. 2021 Dec 16;58(6):
pubmed: 34140301
Eur Respir J. 2021 Dec 2;58(6):
pubmed: 34083402
Am J Transplant. 2011 May;11(5):911-22
pubmed: 21521466
J Immunol. 2011 Sep 15;187(6):3003-14
pubmed: 21841134
Am J Respir Crit Care Med. 2015 Sep 15;192(6):763-5
pubmed: 26371815
Am J Respir Crit Care Med. 2011 Nov 15;184(10):1153-63
pubmed: 21852540
QJM. 2018 Apr 01;111(4):217-224
pubmed: 29237089
Cell. 2017 Mar 9;168(6):960-976
pubmed: 28283069
J Hypertens. 2011 Sep;29(9):1820-8
pubmed: 21785365
Eur Respir J. 2021 Mar 18;57(3):
pubmed: 32943400
J Thorac Oncol. 2018 Aug;13(8):1076-1082
pubmed: 29763666
Cancer Res. 2008 Jun 15;68(12):4774-82
pubmed: 18559524
Eur Respir J. 1998 Oct;12(4):913-9
pubmed: 9817168
Science. 2000 Oct 6;290(5489):127-31
pubmed: 11021796
Am J Respir Crit Care Med. 2006 Apr 1;173(7):781-92
pubmed: 16415274
Exp Mol Pathol. 2009 Dec;87(3):212-8
pubmed: 19527710
J Exp Med. 2010 Mar 15;207(3):535-52
pubmed: 20176803
Sarcoidosis Vasc Diffuse Lung Dis. 2018;35(3):213-217
pubmed: 32476905
Nat Rev Immunol. 2005 Mar;5(3):243-51
pubmed: 15738954
Thorax. 2003 Jun;58(6):519-24
pubmed: 12775866
Postgrad Med J. 1970 Aug;46(538):530-6
pubmed: 5481107
PLoS One. 2011;6(8):e23185
pubmed: 21858022
PLoS One. 2016 Feb 04;11(2):e0148207
pubmed: 26845566
Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50
pubmed: 16199517
J Breath Res. 2013 Dec;7(4):046003
pubmed: 24091835
Nat Rev Dis Primers. 2019 Jul 4;5(1):45
pubmed: 31273209
J Exp Med. 2014 Jan 13;211(1):89-104
pubmed: 24395888
Blood. 2008 Jul 15;112(2):362-73
pubmed: 18354038
Lancet Respir Med. 2019 Jun;7(6):497-508
pubmed: 30935881
Cell. 2015 Oct 8;163(2):381-93
pubmed: 26411290
Thorax. 2011 Feb;66(2):144-50
pubmed: 21139119
Hum Immunol. 2018 Jan;79(1):63-69
pubmed: 29107084
Respir Med. 2010 Apr;104(4):571-7
pubmed: 19954940
J Exp Med. 2006 Feb 20;203(2):359-70
pubmed: 16432251
J Immunol. 1998 Feb 1;160(3):1411-8
pubmed: 9570561
Int J Rheum Dis. 2017 Sep;20(9):1277-1285
pubmed: 28480561
Respirology. 2005 Sep;10(4):535-40
pubmed: 16135181
Chest. 2006 Jun;129(6):1584-91
pubmed: 16778279
Eur Respir J. 2010 Mar;35(3):695-7
pubmed: 20190336
N Engl J Med. 2004 Jan 8;350(2):125-33
pubmed: 14711911
Sci Transl Med. 2018 Sep 26;10(460):
pubmed: 30257954
Front Immunol. 2021 Mar 30;12:595811
pubmed: 33859634
J Clin Immunol. 2013 Feb;33(2):446-55
pubmed: 23073617
Semin Arthritis Rheum. 2012 Oct;42(2):206-12
pubmed: 22572392
Tissue Antigens. 2012 Jan;79(1):25-32
pubmed: 22150367
Am J Respir Cell Mol Biol. 2001 May;24(5):545-55
pubmed: 11350823
Science. 2019 Mar 15;363(6432):
pubmed: 30872492
Eur J Immunol. 2014 Jul;44(7):2165-74
pubmed: 24723379
Mol Med. 2018 Aug 30;24(1):46
pubmed: 30165816
Front Immunol. 2021 Aug 11;12:719009
pubmed: 34456926
Am J Respir Cell Mol Biol. 2003 Sep;29(3 Suppl):S37-41
pubmed: 14503552
J Immunol. 2013 Jun 1;190(11):5446-53
pubmed: 23630356
Clin Exp Immunol. 2016 Feb;183(2):294-306
pubmed: 26415669
Am J Respir Crit Care Med. 2014 Sep 1;190(5):560-71
pubmed: 25073001
Cells. 2021 Mar 07;10(3):
pubmed: 33799927
Eur Respir J. 2018 Mar 1;51(3):
pubmed: 29449421
J Transl Med. 2009 May 20;7:35
pubmed: 19457253
J Mol Cell Biol. 2012 Feb;4(1):29-37
pubmed: 22158907
Lancet. 2009 Jul 18;374(9685):222-8
pubmed: 19570573
N Engl J Med. 2019 Oct 31;381(18):1718-1727
pubmed: 31566307
J Thorac Dis. 2019 Sep;11(9):4005-4017
pubmed: 31656675
Curr Opin Pulm Med. 2016 Sep;22(5):484-91
pubmed: 27379967
J Immunol. 2011 Sep 1;187(5):2814-23
pubmed: 21804025
Ann Am Thorac Soc. 2013 Aug;10(4):362-70
pubmed: 23952859
J Exp Med. 2001 Sep 17;194(6):809-21
pubmed: 11560996
Nat Med. 2012 Jul 06;18(7):1028-40
pubmed: 22772564
ERJ Open Res. 2022 Feb 28;8(1):
pubmed: 35237683
Am J Surg Pathol. 2013 Apr;37(4):593-600
pubmed: 23426125
J Immunol. 2004 Sep 15;173(6):4020-9
pubmed: 15356151

Auteurs

Praveen Weeratunga (P)

Oxford Sarcoidosis Clinic, Oxford Interstitial Lung Disease Service, Oxford, UK.
MRC Human Immunology Unit, University of Oxford, Oxford, UK.

David R Moller (DR)

Department of Medicine, Johns Hopkins University, Baltimore, MD, USA.

Ling-Pei Ho (LP)

Oxford Sarcoidosis Clinic, Oxford Interstitial Lung Disease Service, Oxford, UK ling-pei.ho@imm.ox.ac.uk.
MRC Human Immunology Unit, University of Oxford, Oxford, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH